Literature DB >> 15224376

Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia.

Naglaa A Fawaz1, Layla Bashawery, Iman Al-Sheikh, Ahlam Qatari, Sara S Al-Othman, Wassim Y Almawi.   

Abstract

The prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations were investigated among 87 Saudi sickle cell disease (SCD) patients (38 males and 49 females) and 105 healthy controls (65 males and 40 females). The prevalences of factor V Leiden (P = 0.174) and PRT G20210A (P = 0.397) were not different between patients and controls, thereby giving no support to an association of either single-point mutation with SCD. However, an increased prevalence of the MTHFR 677 T/T genotype was seen among patients (8/87) compared to controls (4/105), but this was not statistically significant (P = 0.217; OR = 2.56). This suggested a low impact of inherited hypercoagulability risk factors in the pathogenesis of SCD and/or its complications. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15224376     DOI: 10.1002/ajh.20087

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  5 in total

1.  HLA class II haplotypes distinctly associated with vaso-occlusion in children with sickle cell disease.

Authors:  Najat Mahdi; Khadija Al-Ola; Abeer M Al-Subaie; Muhallab E Ali; Zaid Al-Irhayim; A Qader Al-Irhayim; Wassim Y Almawi
Journal:  Clin Vaccine Immunol       Date:  2008-02-13

Review 2.  Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.

Authors:  Zahra Pakbaz; Ted Wun
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

3.  Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.

Authors:  Zohreh Rahimi; Asad Vaisi-Raygani; Ronald L Nagel; Adriana Muniz
Journal:  J Thromb Thrombolysis       Date:  2007-07-11       Impact factor: 2.300

4.  Sickle cell disease and venous thromboembolism.

Authors:  Zohreh Rahimi; Abbas Parsian
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-05-24       Impact factor: 2.576

5.  Factor V Leiden G1691A and prothrombin G20210A mutations among Palestinian patients with sickle cell disease.

Authors:  Fekri Samarah; Mahmoud A Srour
Journal:  BMC Hematol       Date:  2018-01-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.